The FDA Law Blog
NOVEMBER 29, 2022
Before starting opioid therapy for subacute or chronic pain, clinicians should discuss with patients the realistic benefits and known risks of opioid therapy, should work with patients to establish treatment goals for pain and function, and should consider how opioid therapy will be discontinued if benefits do not outweigh risks.
European Pharmaceutical Review
DECEMBER 21, 2022
Most psychedelic drugs are Schedule I controlled substances, which means that very strict legal and regulatory controls accompany their use” Some psychedelics originate in nature and have been used by Indigenous cultures for thousands of years; others are manipulated or manufactured. Breakthrough therapy designation.
The Checkup by Singlecare
MARCH 30, 2023
Control your controls If your biennial controlled substance inventory is due this year, now is the time to start preparing. Ensure all controlled substances are stored properly. For example, over-the-counter hearing aids are now FDA-approved—is your pharmacy stocked and ready?
Expert insights. Personalized for you.
52 
Let's personalize your content